1. |
Boudina S, Abel ED. Diabetic cardiomyopathy revisited. Circulation 2007; 115:3213-23.
|
2. |
Fang ZY, Prins JB, Marwick TH. Diabetic cardiomyopathy: Evidence, mechanisms, and therapeutic implications. Endocr Rev 2004; 25:543-67.
|
3. |
Rubler S, Dlugash J, Yuceoglu YZ, et al. New type of cardiomyopathy associated with diabetic glomerulos- clerosis. Am J Cardiol 1972; 30:595-602.
|
4. |
Eguchi K, Boden-Albala B, Jin Z, et al. Association between diabetes mellitus and left ventricular hypertrophy in a multiethnic population. Am J Cardiol 2008; 101:1787-91.
|
5. |
Dawson A, Morris AD, Struthers AD. The epidemiology of left ventricular hypertrophy in type 2 diabetes mellitus. Diabetologia 2005; 48:1971-9.
|
6. |
Nkum BC, Micah FB, Ankrah TC, et al. Left ventricular hypertrophy and insulin resistance in adults from an urban community in the Gambia: Cross-sectional study. PLoS One 2014; 9:e93606.
|
7. |
Becerra-Tomás N, Estruch R, Bullo M, et al. Increased serum calcium levels and risk of type 2 diabetes in individuals at high cardiovascular risk. Diabetes Care 2014; 37:3084-91.
|
8. |
Song X, Bishop JE, Okamura WH, et al. Stimulation of phosphorylation of mitogenactivated protein kinase by 1alpha, 25-dihydroxy vitamin D3 in promyelocytic NB4 leukemia cells: A structure-function study. Endocrinology 1998; 139:457-65.
|
9. |
Nemerovski CW, Dorsch MP, Simpson RU, et al. Vitamin D and cardiovascular disease. Pharmacotherapy 2009; 29:691-708.
|
10 |
Tishkoff DX, Nibbelink KA, Holmberg KH, et al. Functional vitamin D receptor (VDR) in the t-tubules of cardiac myocytes: VDR knockout cardiomyocyte contractility. Endocrinology 2008; 149:558-64.
|
11 |
de Simone G, Wallerson DC, Volpe M, et al. Echo- cardiographic measurement of left ventricular mass and volume in normotensive and hypertensive rats. Necropsy validation. Am J Hypertens 1990; 3:688-96.
|
12 |
de Simone G, Devereux RB, Wallerson DC. Echocardio- graphic assessment of left ventricular hypertrophy in rats using a simplified approach. Am J Hypertens 1994; 7: 555-8.
|
13 |
Xu Shuyun. Pharmacological experimental methodology. 2nd ed. Beijing: People's Health Press; 1982.
|
14 |
Bell DS. Diabetic cardiomyopathy. A unique entity or a complication of coronary artery disease? Diabetes Care 1995; 18:708-14.
|
15 |
Giles TD, Ouyang J, Kerut EK, et al. Changes in protein kinase C in early cardiomyopathy and in gracilis muscle in the BB/Wor diabetic rat. Am J Physiol 1998; 274: H295-307.
|
16 |
Lu X, Yang XY, Howard RL, et al. Fatty acids modulate protein kinase C activation in porcine vascular smooth muscle cells independently of their effect on de novo diacylglycerol synthesis. Diabetologia 2000; 43:1136-44.
|
17 |
Tyagi SC, Hayden MR. Role of nitric oxide in matrix remodeling in diabetes and heart failure. Heart Fail Rev 2003; 8:23-8.
|
18 |
Nishikawa N, Yamamoto K, Sakata Y, et al. Differential activation of matrix metalloproteinases in heart failure with and without ventricular dilatation. Cardiovasc Res 2003; 57:766-74.
|
19 |
Palomer X, Gonzalez-Clemente JM, Blanco-Vaca F, et al. Role of vitamin D in the pathogenesis of type 2 diabetes mellitus. Diabetes Obes Metab 2008; 10:185-97.
|
20 |
Chiu KC, Chu A, Go VL, et al. Hypovitaminosis D is asso- ciated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 2004; 79:820-5.
|
21 |
Borissova AM, Tankova T, Kirilov G, et al. The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients. Int J Clin Pract 2003; 57:258-61.
|
22 |
Mattila C, Knekt P, Männistö S, et al. Serum 25-hydroxy vitamin D concentration and subsequent risk of type 2 diabetes. Diabetes Care 2007; 30:2569-70.
|
23 |
Pittas AG, Dawson-Hughes B, Li T, et al. Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care 2006; 29:650-6.
|
24 |
Wu J, Garami M, Cao L, et al. 1, 25(OH) 2 D 3 suppresses expression and secretion of atrial natriuretic peptide from cardiac myocytes. Am J Physiol 1995; 268:E1108-13.
|
25 |
Chen S, Gardner DG. Retinoic acid uses divergent mechanisms to activate or suppress mitogenesis in rat aortic smooth muscle cells. J Clin Invest 1998; 102:653-62.
|
26 |
Chen S, Costa CH, Nakamura K, et al. Vitamin D-dependent suppression of human atrial natriuretic peptide gene promoter activity requires heterodimer assembly. J Biol Chem 1999; 274:11260-6.
|
27 |
Xiang W, Kong J, Chen S, et al. Cardiac hypertrophy in vitamin D receptor knockout mice: Role of the systemic and cardiac renin-angiotensin systems. Am J Physiol Endocrinol Metab 2005; 288:E125-32.
|
28 |
Bodyak N, Ayus JC, Achinger S, et al. Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals. Proc Natl Acad Sci USA 2007; 104:16810-5.
|
29 |
Uysal S, Kalayci AG, Baysal K. Cardiac functions in children with vitamin D deficiency rickets. Pediatr Cardiol 1999; 20:283-6.
|
30 |
Park CW, Oh YS, Shin YS, et al. Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism. Am J Kidney Dis 1999; 33:73-81.
|
31 |
Chen S, Glenn DJ, Ni W, et al. Expression of the vitamin D receptor is increased in the hypertrophic heart. Hypertension 2008; 52:1106-12.
|